About this item
- Control Blood pressure regulation
- Maintain Cholesterol & LDL Levels
- Serenocard is a pre-probiotic composition scientifically designed by CSIR-IMTECH focusing on the rebalancing the structural and functional changes in gut microbiota favouring prevention of cardiovascular diseases along with maintaining its immune homeostasis.
- The gut microbiota is mechanistically linked to systemic inflammation and endothelial function.
- Lactiplantibacillus plantarum improves endothelial function for both conduit and resistance vessels by increasing nitric oxide bioavailability and concurrently reducing systemic inflammation, as measured by brachial artery flow-mediated dilation.
- Probiotic Lactiplantibacillus plantarum and Streptococcus thermophilus enhances nitric oxide production and enhanced nitric oxide synthase (eNOS) activity in endothelial cells for efficacious endothelial function.
- Increased Gram-negative bacteria, lipopolysaccharide (LPS) levels compromise the cardiovascular function and increase the CVD risk. Probiotic Lacticaseibacillus rhamnosus and Prebiotic Inulin plays a significant role in reduction of LPS levels thereby mitigating the CVD risk.
- Limosilactobacillus reuterii and Lactobacillus acidophilus lowers the levels of inflammation biomarkers TNF-α, IL-6, IL-8 thereby reducing the CVD risk.
- Lactobacillus acidophilus increases HDL cholesterol levels thereby lowering the risk of heart disease and stroke.
- Bifidobacterium bifidum inhibit lipid peroxidation and ROS production and, as a result, may slow or even prevent the development of CVDs and other oxidative stress-related diseases. Saccharomyces cerevisiae and its metabolites shows beneficial effect in treatment of cardiovascular diseases.
No Reviews Found